Dural Graft Marketing: Clinical Claims That Stay Accurate

Accurate claims build trust with surgeons and hospitals. What distributors can say about DURASHEET and DECOLL, what to avoid and how to review materials.
Key Takeaways
- Every claim about a dural graft should trace back to the product documentation.
- Outcome promises, superlatives and unsupported comparisons damage credibility.
- Fair comparisons describe features, not competitors’ weaknesses.
- A simple review step with the manufacturer prevents most problems.
Accurate dural graft marketing says what the product is and how it is intended to be used, and stops there. For DURASHEET and DECOLL, that means material, sizes, placement options, sterility and quality system, all traceable to DESU’s documentation. Outcome promises, superlatives and unsupported comparisons undermine trust with surgeons, committees and hospital reviewers.
Distributors and independent agencies often create their own materials: sell sheets, emails, social posts, presentations for value analysis committees. This article gives them a practical framework for keeping those materials accurate when promoting collagen dural grafts such as DURASHEET and DECOLL.
Why does accuracy matter more for an implant?
A dural graft is implanted in the central nervous system. The people who read marketing materials about it are neurosurgeons, OR nurses, value analysis committees and quality teams, and they are trained to spot claims that go beyond the evidence. An exaggerated sentence in a brochure is not just a compliance problem; it tells the reader that the rest of the document cannot be trusted either.
Medical device promotion is also subject to rules in most markets, and manufacturers are responsible for the claims made about their products. A distributor that invents claims puts both itself and the manufacturer at risk. Accuracy protects the relationship as well as the reader.
Claims also travel. A sentence written for one email ends up in a presentation, then in a value analysis packet, then in a hospital’s own product summary. An inaccurate claim is very hard to withdraw once it has spread through an account.
There is a commercial argument too. Hospitals increasingly ask suppliers to substantiate every claim in their materials. Claims that are simple, documented and modest are easy to substantiate. Claims that are ambitious and vague create work, delay and doubt.
What can be said about DURASHEET and DECOLL?
The safest and most persuasive claims are the documented facts, stated plainly. For DESU’s collagen dura membranes, those include:
- Both are made from pure Type I bovine collagen.
- Both are supplied in four sizes.
- DURASHEET is a dural graft matrix that is usable on both surfaces and suturable.
- DECOLL is a collagen dura membrane designed for onlay use.
- Both are ready to use and gamma sterilized.
- Both are made by DESU in its own cleanrooms in Ankara, Türkiye, under an ISO 13485 quality management system, and carry the CE mark.
- DESU has designed and manufactured medical devices since 2007 and exports to more than 50 countries.
These statements are specific, verifiable and relevant. A surgeon reading them learns exactly what the product is. A committee member can check them against the documentation. Nothing more is needed to start a serious conversation.
Which claims should be avoided?
The following kinds of statement appear regularly in dural graft marketing and should be avoided unless the manufacturer has specific, documented support for them.
| Avoid | Why | Say instead |
|---|---|---|
| “Stops CSF leaks” or “ensures a watertight closure” | Closure depends on the patient, technique and many other factors | “Designed for dural repair, sutured or onlay as described in the instructions for use” |
| “The best” or “the most advanced” dural graft | Superlatives cannot be substantiated | State the specific feature: “usable on both surfaces” |
| Specific resorption times or healing rates | Not part of the product facts you hold | Refer questions to DESU’s documentation |
| “No risk” of disease transmission | No biological material carries zero theoretical risk | “Pure Type I bovine collagen; ask DESU for information on animal-origin controls” |
| “Reduces infections” | Infection depends on many factors outside the graft | “Gamma sterilized and ready to use” |
| Statements about registration status in a market | Status differs by country and changes | Confirm with DESU before any such statement |
The “say instead” column is not weaker. To an informed reader it is stronger, because it is credible. It also survives scrutiny: if a value analysis committee asks for the source of a statement, the distributor can point to the product documentation immediately rather than searching for evidence that does not exist.
How should comparisons with other products be handled?
Comparisons are useful when they help a surgeon or committee understand a choice. They become a problem when they name competitors, disparage them or rely on information the distributor cannot verify.
A fair approach compares features, not brands. For example, a presentation can explain that the department’s options include autologous tissue, collagen matrices and synthetic substitutes, describe the general characteristics of each family and then state DESU’s documented features. It should not claim that another product handles poorly or fails more often.
If a surgeon asks for a direct comparison with a specific product, the honest answer is to describe what DESU’s grafts are and let the surgeon judge from their own experience, ideally through an evaluation.
The same applies to price comparisons in written materials. Unit prices vary by contract, size and volume, and a published comparison is likely to be out of date or misleading for a particular hospital. Price belongs in a proposal addressed to a specific account, not in general marketing.
What about surgeon testimonials and case stories?
Real experience from surgeons who use a product is persuasive, but it must be handled carefully. Quotes and case descriptions should only be used with the surgeon’s explicit, written permission, exactly as the surgeon said them, and in line with the hospital’s policies. Invented or paraphrased endorsements are never acceptable.
Case stories must not identify patients, and clinical images should not be used without the hospital’s formal permission and patient consent processes. In most distributor materials, it is simpler and safer to focus on product facts and to invite readers to talk to surgeons who use the product directly.
How should digital and social content be handled?
Short formats invite shortcuts. A social post or an email subject line has room for one idea, and the temptation is to make it a strong one. The same standards apply, however: a post that says “the graft surgeons trust for leak-free closure” makes an outcome claim, however briefly.
Short content works best when it points to something specific and documented: a product feature, an upcoming in-service, a new size becoming available in the territory or an invitation to an evaluation. Link to the manufacturer’s product page so the reader can see the full description.
Images need care too. DESU does not use photographs of people in its own materials, and distributors should avoid images of patients or identifiable OR staff. Product images and neutral illustrations are the safer choice.
How should materials be reviewed before use?
Most problems are prevented by a simple review step. Before a new sell sheet, presentation or post goes out, check it against a short list:
- Is every product statement found in DESU’s documentation or product pages?
- Are any outcomes promised, directly or by implication?
- Are competitors named or disparaged?
- Are product names written correctly: DESU, DURASHEET, DECOLL?
- Has the manufacturer seen the material, if it makes any claim beyond the basic facts?
DESU’s product pages and catalogues are the reference for product facts. Where a distributor wants to say something not covered there, the right step is to ask DESU first. Keep a record of what was reviewed and when, so that materials can be updated consistently if product information changes.
Talk to a DESU product specialist
If you are preparing marketing materials for DURASHEET or DECOLL and want them checked against DESU’s documentation, or need suitable wording for a specific claim, DESU’s product specialists can help. Write to sales@desu.tr or use the contact page.
Frequently Asked Questions
Can a distributor say that a dural graft prevents CSF leaks?
No. CSF leaks depend on the patient, the procedure, the surgeon’s technique and the closure of overlying tissues. No graft can promise to stop them. Describe what the product is and how it is intended to be used, according to the instructions for use, and let surgeons judge from experience.
What are the core facts to use when marketing DURASHEET and DECOLL?
Both are pure Type I bovine collagen, in four sizes, ready to use and gamma sterilized. DURASHEET is usable on both surfaces and suturable; DECOLL is designed for onlay use. Both are made by DESU in its own cleanrooms under ISO 13485 and carry the CE mark.
Can I compare DESU grafts with a named competitor?
It is better not to. Compare features and material families rather than brands, and avoid statements about other products that you cannot verify. If a surgeon wants a direct comparison, an evaluation with their own cases is the most honest way to provide one.
Should DESU review distributor marketing materials?
For anything beyond the basic documented facts, yes. Sharing new materials with a DESU product specialist before use helps ensure that claims match the product documentation and that product names and descriptions are correct. It also protects the distributor and the manufacturer.
Sources
- ISO 13485:2016 Medical devices — Quality management systems — Requirements for regulatory purposes
- ISO 22442 series: Medical devices utilizing animal tissues and their derivatives
- ISO 10993 series: Biological evaluation of medical devices
- Regulation (EU) 2017/745 on medical devices
Talk to a specialist about this topic
Reach our team directly for product selection, technical specifications, sample requests or distributor enquiries.
Comments
No comments yet. Be the first to write one.